Comparative Study between the Effect of Perineural versus Intravascular Dexmedetomidine in Ultrasound-Guided Supraclavicular Brachial Plexus Block
Mahmoud A. Al Mohasseb, Wael E. Messbah, Sabry M. Amin, Nadia H. Fattooh
Journal of Advances in Medicine and Medical Research · pp. 37–45 · Published 24 Jul 2020
10.9734/jammr/2020/v32i1130531Abstract
Background: Augmentation of postoperative analgesia with various adjuvants has become a standard in regional anesthesia. There are no studies about dexmedetomidine multiple approaches in supraclavicular brachial plexus block (BPB) was contrasted. We compare perineural dexmedetomidine and intravenous dexmedetomidine Bupivacaine as adjuvant in supraclavicular brachial plexus block. Materials and Methods: This prospective randomized controlled double-blind study was conducted on 120 patients with age between 20 and 60 years, both sexes, scheduled for elective upper limb surgery. Patients were randomly allocated into 3 groups, 40 patients in each received plain bupivacaine 0.5% (20 ml) in supraclavicular BPB; group I (Control group): add 1 mL normal saline perineural, group II: Bupivacaine with perineural dexmedetomidine (BDP) add 1 μg.kg-1dexmedetomidine perineurally. group III: Bupivacaine with intravenous dexmedetomidine (BDV) add 0.5 μg.kg-1 dexmedetomidine in 50 mL of normal saline administered as infusion over 10 min. Onset and duration of sensory and motor blocks, hemodynamic variables, adverse effects, and duration of analgesia were assessed. Results: Heart rate and mean arterial pressure was significantly decrease in group III &group II compared to group I were compared by ANOVA (F) test. onset of sensory &motor block was statistically significant shorter in group II compared to group I & III. Duration of sensory &motor block was statistically significant longer in group II compared to group I & III. there was statistically significant decrease VAS in group II were analysed using Kruskal-Wallis test between three groups. There was statistically significant increase RSS in group II & III. The first time of analgesic request was statistically significant prolonged in duration in group II. Conclusion: Perineural dexmedetomidine (1 µg/ kg) as an adjuvant to bupivacaine is significantly high thanIV dexmedetomidine (0.5 µg/ kg) and bupivacaine alone in supraclavicular BPB as regards to the onset and the duration of sensory block, so Increasingpostoperative analgesia.
Cited by 2
Nasir Hussain, Chad M Brummett, Richard Brull · Regional Anesthesia & Pain Medicine · 2021
Jakob H. Andersen, Anders Karlsen, Anja Geisler · Acta Anaesthesiologica Scandinavica · 2021
Related research
- A Prospective Study Comparing 0.25% Bupivacaine and 0.375% Ropivacaine in Transversus Abdominis Plane Block for Postoperative Analgesia in Laparoscopic Abdominal Surgery — shares topic coverage
- Measurement of the Outcome of Low Dose of 0.5% Bupivacaine Heavy in Spinal Anesthesia during Lower Segment Cesarean Section (LSCS) — shares topic coverage
- Evaluation of Bupivacaine Co-administration with Midazolam or Neostigmine in Pediatric Inguinal Hernia Surgery-A Randomized Clinical Trial Study — shares topic coverage
- Postoperative Pain Relief Following Bupivacaine Injection in Sites & Intraperitoneal Spray of Laparoscopic Cholecystectomy — shares topic coverage
- Clinical Comparison of Bupivacaine and Lidocaine for Local Anesthesia in Glaucoma Surgery — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
2
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.